Aeon Global Health Corp. (AGHC) Financial Statements (2023 and Earlier)

Company Profile

Business Address 2225 CENTENNIAL DRIVE
GAINESVILLE, 30504
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7547231,1221,4152471,294
Cash and cash equivalents7547231,1221,4152471,084
Short-term investments     210
Restricted cash and investments  121121256256
Receivables1,5412,5071,0212,143274508
Inventory, net of allowances, customer advances and progress billings6544533483386032,937
Inventory6544533483386032,937
Other undisclosed current assets145459171222259
Total current assets:2,9633,7382,6704,1871,6025,254
Noncurrent Assets
Property, plant and equipment9481,4212,2043,477301448
Intangible assets, net (including goodwill)   5,5074,0684,121
Goodwill   3,3185050
Intangible assets, net (excluding goodwill)   2,1894,0184,071
Deposits noncurrent assets  1010  
Other noncurrent assets    356593
Deferred tax assets, net 5,81611,84838,493  
Other undisclosed noncurrent assets    (2,164)(2,188)
Total noncurrent assets:9487,23714,06247,4872,5612,974
TOTAL ASSETS:3,91110,97516,73251,6734,1638,228
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,4295,1754,9916,4822,1092,806
Accounts payable2,0871,4372,1784,3291,410 
Accrued liabilities2,9932,2382,1682,153569 
Taxes payable6516    
Interest and dividends payable343985645   
Other undisclosed accounts payable and accrued liabilities    1302,806
Debt 3,050 2,9782,150 
Deferred rent credit206195
Derivative instruments and hedges, liabilities2871,324551   
Due to related parties1,698 2,545   
Deferred revenue and credits 142 6778
Other undisclosed current liabilities6456084282,158214 
Total current liabilities:8,26510,3528,65611,6184,5402,884
Noncurrent Liabilities
Liabilities, other than long-term debt1,6281354511488126
Deferred revenue and credits 4511488126
Deferred rent credit212135
Due to related parties1,415     
Total noncurrent liabilities:1,6281354511488126
Total liabilities:9,89310,4878,70111,7324,6283,010
Stockholders' equity
Stockholders' equity attributable to parent(5,982)4898,03039,941(465)5,218
Preferred stock636363636969
Common stock1026964239
Additional paid in capital47,70345,08944,30738,316205,909201,492
Retained earnings (accumulated deficit)(53,758)(44,689)(36,349)1,556(206,485)(196,382)
Total stockholders' equity:(5,982)4898,03039,941(465)5,218
TOTAL LIABILITIES AND EQUITY:3,91110,97516,73251,6734,1638,228

Income Statement (P&L) ($ in thousands)

6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues12,93216,30120,19934,5773,6895,556
Revenue, net 20,19934,5773,6895,556
Cost of revenue(5,010)(3,802)(4,200)(6,877)(1,877)(3,759)
Gross profit:7,92212,49915,99827,7001,8121,797
Operating expenses(10,466)(12,498)(15,956) (10,707)(12,673)
Other undisclosed operating income (loss)(406)(782)(5,422)(21,903)1893,759
Operating income (loss):(2,950)(781)(5,379)5,797(8,706)(7,117)
Nonoperating income (expense)282(1,123)(46)(207)(994)(26)
Investment income, nonoperating579(773)828   
Other nonoperating expense(114)(210)(160)  (26)
Interest and debt expense (42)(258)(115)(592)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(2,668)(1,945)(5,684)5,475(10,292)(7,144)
Other undisclosed income from continuing operations before income taxes 42258115  
Income (loss) from continuing operations before income taxes:(2,668)(1,903)(5,426)5,590(10,292)(7,144)
Income tax expense(5,307)(6,097)(26,648)(325)  
Net income (loss):(7,975)(8,000)(32,074)5,265(10,292)(7,144)
Other undisclosed net income attributable to parent    5921
Net income (loss) attributable to parent:(7,975)(8,000)(32,074)5,265(9,700)(7,143)
Preferred stock dividends and other adjustments(343)(340)(359)(160)  
Other undisclosed net loss available to common stockholders, basic    (403)(2,419)
Net income (loss) available to common stockholders, basic:(8,318)(8,340)(32,432)5,105(10,103)(9,562)
Interest on convertible debt   46  
Convertible preferred dividends   160  
Net income (loss) available to common stockholders, diluted:(8,318)(8,340)(32,432)5,311(10,103)(9,562)

Comprehensive Income ($ in thousands)

6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):(7,975)(8,000)(32,074)5,265(10,292)(7,144)
Comprehensive income (loss):(7,975)(8,000)(32,074)5,265(10,292)(7,144)
Other undisclosed comprehensive income, net of tax, attributable to parent    5921
Comprehensive income (loss), net of tax, attributable to parent:(7,975)(8,000)(32,074)5,265(9,700)(7,143)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: